{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T12:51:49Z","timestamp":1774875109222,"version":"3.50.1"},"reference-count":5,"publisher":"Danish Medical Association","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ugeskr L\u00e6ger"],"abstract":"<jats:p>A 29-year-old male with prior testicular cancer and daily ketamine use developed severe lower urinary tract symptoms due to bladder fibrosis. Despite multiple treatments \u2013 botulinum toxin type A , bladder distension, and medications - his condition progressed to hydronephrosis, recurrent urosepsis, and acute kidney injury requiring nephrostomies. Eventually, a Bricker bladder was created. The case highlights ketamine-associated uropathy as an ongoing and underrecognized issue, stressing the importance of early cessation and targeted intervention.<\/jats:p>","DOI":"10.61409\/v08250665","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T10:56:25Z","timestamp":1773831385000},"page":"1-3","source":"Crossref","is-referenced-by-count":0,"title":["Bladder dysfunction after ketamine abuse"],"prefix":"10.61409","author":[{"given":"Anders Borg","family":"Andersen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reem Falah Kadhum","family":"Alrubaie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten","family":"J\u00f8nler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommy Kj\u00e6rgaard","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"40208","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"key":"ref0","unstructured":"EUDA European union drugs agency. Wastewater analysis and drugs: European multi-city study, 2025. https:\/\/www.euda.europa.eu\/publications\/html\/pods\/waste-water-analysis_en. (17. sep 2025)"},{"key":"ref1","unstructured":"EUDA European union drugs agency. Other drugs - the current situation in Europe (European Drug Report 2025), 2025. https:\/\/www.euda.europa.eu\/publications\/european-drug-report\/2025\/other-drugs_en. (17. sep 2025)"},{"key":"ref2","unstructured":"Reinhardt S, Fode M. Bl\u00e6resmerter og vandladningsforstyrrelser som f\u00f8lge af ketaminmisbrug. Ugeskr L\u00e6ger 2014;176:V11120682. https:\/\/ugeskriftet.dk\/videnskab\/blaeresmerter-og-vandladningsforstyrrelser-som-folge-af-ketaminmisbrug (2. maj 2025)"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Belal M, Downey A, Doherty R, et al. British Association of Urological Surgeons consensus statements on the management of ketamine uropathy. BJU Int. 2024;134(2):148-154. https:\/\/doi.org\/10.1111\/bju.16404","DOI":"10.1111\/bju.16404"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Zheng Z, Li Z, Yuan J, et al. Ketamine-associated upper urinary tract dysfunction: what we know from current literature. Asian J Urol. 2025;12(1):33-42. https:\/\/doi.org\/10.1016\/j.ajur.2024.05.004","DOI":"10.1016\/j.ajur.2024.05.004"}],"container-title":["Ugeskrift for L\u00e6ger"],"original-title":[],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T11:43:13Z","timestamp":1774870993000},"score":1,"resource":{"primary":{"URL":"https:\/\/ugeskriftet.dk\/videnskab\/V08250665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":5,"URL":"https:\/\/doi.org\/10.61409\/v08250665","relation":{},"ISSN":["0041-5782","1603-6824"],"issn-type":[{"value":"0041-5782","type":"print"},{"value":"1603-6824","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]}}}